214 related articles for article (PubMed ID: 31687021)
1. Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.
Deng M; Wu H; Yu M; Tian Y; Li Y; Xiao X
Int J Endocrinol; 2019; 2019():7959615. PubMed ID: 31687021
[TBL] [Abstract][Full Text] [Related]
2. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
3. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
4. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
5. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
[TBL] [Abstract][Full Text] [Related]
8. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
[TBL] [Abstract][Full Text] [Related]
9. Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature.
Zhu B; Wu J; Chen G; Yang Y; Yi C
Front Endocrinol (Lausanne); 2019; 10():474. PubMed ID: 31379742
[TBL] [Abstract][Full Text] [Related]
10. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
Morita C; Yanase T; Shiohara T; Aoyama Y
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30368475
[TBL] [Abstract][Full Text] [Related]
11. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
[TBL] [Abstract][Full Text] [Related]
12. Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis.
Krivda LK; Campagna LJ; Mignano MS; Cho CS
Fed Pract; 2022 Aug; 39(8):350-354. PubMed ID: 36425806
[TBL] [Abstract][Full Text] [Related]
13. Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM; Chikova IA; Kostik MM
Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
[TBL] [Abstract][Full Text] [Related]
14. Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.
Ogawa K; Mitsui Y; Miyamoto S; Nakamura-Nishimura Y; Nakanishi Y; Azukizawa H; Asada H
J Cutan Pathol; 2019 May; 46(5):363-367. PubMed ID: 30666704
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Lee ES; Kiuchi Y; Inomata N; Sueki H
J Dermatol; 2023 Mar; 50(3):387-392. PubMed ID: 36121111
[TBL] [Abstract][Full Text] [Related]
17. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.
Stirton H; Shear NH; Dodiuk-Gad RP
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625735
[TBL] [Abstract][Full Text] [Related]
18. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis.
Moling O; Tappeiner L; Piccin A; Pagani E; Rossi P; Rimenti G; Vedovelli C; Mian P
Med Sci Monit; 2012 Jul; 18(7):CS57-62. PubMed ID: 22739739
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
20. Drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of multi-visceral abnormalities and long-term outcome.
Bhatt KP; Alsoud F; Prashad A; Ortega-Tola J; Singh VR; Patel P; Michel G
Discoveries (Craiova); 2023; 11(1):e170. PubMed ID: 37680345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
